Dr. Yun Namkung, MD

Dr. Namkung practices at William Bee Ririe Hospital - Clinic in Ely, Nevada.

Dr. Namkung's NPI, 1053451955, was assigned on February 8, 2007. Dr. Namkung holds Nevada license 13058.

Dr. Namkung's primary practice is William Bee Ririe Hospital - Clinic, at 6 Steptoe Circle, Ely, NV 89301. The practice phone is (775) 289-3001. Dr. Namkung also practices at William Bee Ririe Hospital, 5 Steptoe Cir, Ely, NV 89301.

Dr. Namkung's primary practice is William Bee Ririe Hospital - Clinic in Ely, Nevada. Dr. Namkung is also affiliated with William Bee Ririe Critical Access Hospital. The medical group on file is William Bee Ririe Hospital. Dmand AI also links Dr. Namkung to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Namkung practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Namkung's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Namkung is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Namkung's licenses on file in 3 states: Nevada, New York and Wisconsin.

CMS data shows 343 Medicare services from Dr. Namkung across 7 procedure codes in 2024, for 102 Medicare patients. Medicare paid $22,930 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 102 Medicare patients who saw Dr. Namkung in 2024. The largest group is 75 to 84, with 40 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Namkung's median patient age at 69, with 56% women.

In 2024, Dr. Namkung wrote 3,372 Medicare Part D claims for 180 patients. 87% of them were for generic drugs. CMS names the drug for 2,886 of them, across 84 drugs with 11 or more claims each, at $149,605 in total drug cost. In 2023, CMS named 2,733 claims across 78 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 37 out of 100 for Dr. Namkung for performance year 2024, reported as part of a group. Dr. Namkung accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Namkung from 2 drug and device companies from 2018 to 2019. Food and beverage make up the largest share, 100% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $19.